Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 8, Issue 5, 1990, Pages 768-778

  Gianni, A M ^a   Bregni, M ^a   Siena, S ^a   Orazi, A ^a   Stern, A C ^a   Gandola, L ^a   Bonadonna, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE;

AGE; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; DRUG INTERACTION; DRUG THERAPY; FEMALE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0025219465     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1990.8.5.768     Document Type: Article

References (0)